|
CHMP5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.012200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.555100E-04 |
| Normal-vs-Stage2 |
2.813900E-02 |
| Normal-vs-Stage3 |
4.083600E-03 |
| Normal-vs-Stage4 |
2.317900E-02 |
| Stage1-vs-Stage2 |
7.348800E-01 |
| Stage1-vs-Stage3 |
9.577000E-01 |
| Stage1-vs-Stage4 |
8.706800E-01 |
| Stage2-vs-Stage3 |
7.838800E-01 |
| Stage2-vs-Stage4 |
6.974600E-01 |
| Stage3-vs-Stage4 |
8.259200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.648600E-04 |
| Normal-vs-AfricanAmerican |
2.162600E-03 |
| Normal-vs-Asian |
1.087450E-01 |
| Caucasian-vs-AfricanAmerican |
5.592400E-01 |
| Caucasian-vs-Asian |
9.224400E-01 |
| AfricanAmerican-vs-Asian |
7.392600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.37190000000376E-05 |
| Normal-vs-Female |
7.504700E-03 |
| Male-vs-Female |
4.259400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.043420E-03 |
| Normal-vs-Extreme_Weight |
1.228730E-04 |
| Normal-vs-Obese |
4.961300E-03 |
| Normal-vs-Extreme_Obese |
2.005600E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.729200E-01 |
| Normal_Weight-vs-Obese |
4.987400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.194800E-01 |
| Extreme_Weight-vs-Obese |
3.901800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.029400E-01 |
| Obese-vs-Extreme_Obese |
4.649000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.192390E-01 |
| Normal-vs-Age(41-60Yrs) |
1.380590E-03 |
| Normal-vs-Age(61-80Yrs) |
1.625820E-04 |
| Normal-vs-Age(81-100Yrs) |
2.619800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.242600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.714800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.228000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.903000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.507400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.059800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.357400E-04 |
| Normal-VS-Type2 PRCC |
2.361400E-03 |
| Normal-VS-KIRP CIMP |
8.790400E-01 |
| Normal-VS-Unclassified PRCC |
5.573100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.792600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.987700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.857800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.758400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.549200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.428000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.584900E-04 |
| Normal-vs-N1 |
1.743550E-03 |
| Normal-vs-N2 |
1.047710E-02 |
| N0-vs-N1 |
8.146200E-01 |
| N0-vs-N2 |
2.474600E-01 |
| N1-vs-N2 |
2.422600E-01 |
|
|
